ENTRY       D04486                      Drug
NAME        Ibandronate sodium (USAN);
            Ibandronate sodium hydrate (JAN);
            Ibandronate sodium monohydrate;
            Bondronat (TN);
            Boniva (TN);
            Bonviva (TN)
PRODUCT
  GENERIC   IBANDRONATE SODIUM (Alvogen)
            IBANDRONATE SODIUM (Apotex Corp)
            IBANDRONATE SODIUM (Apotex Corp.)
            IBANDRONATE SODIUM (AuroMedics Pharma LLC)
            IBANDRONATE SODIUM (Aurobindo Pharma Limited)
            IBANDRONATE SODIUM (Bionpharma)
            IBANDRONATE SODIUM (Dr. Reddy's Laboratories Limited)
            IBANDRONATE SODIUM (Golden State Medical Supply)
            IBANDRONATE SODIUM (Macleods Pharmaceuticals Limited)
            IBANDRONATE SODIUM (Mylan Institutional LLC)
FORMULA     C9H22NO7P2. Na. H2O
EXACT_MASS  359.0875
MOL_WEIGHT  359.2261
CLASS       Musculo-skeletal system agent
             DG03232  Osteoporosis agent
              DG01600  Bisphosphonate
REMARK      Therapeutic category: 3999
            ATC code: M05BA06
            Chemical structure group: DG00785
            Product (DG00785): D04486<JP/US>
EFFICACY    Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor
  DISEASE   Osteoporosis [DS:H01593]
COMMENT     Bisphosphonate
TARGET      FDPS [HSA:2224] [KO:K00787]
  PATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis
INTERACTION  
STR_MAP     map07047  Osteoporosis drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BA Bisphosphonates
                 M05BA06 Ibandronic acid
                  D04486  Ibandronate sodium (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Bisphosphonates
               Ibandronate
                D04486  Ibandronate sodium (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D04486  Ibandronate sodium (USAN); Ibandronate sodium hydrate (JAN)
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00785  Ibandronic acid
                 D04486  Ibandronate sodium
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D04486  Ibandronate sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Alkyl/Aryl transferases
                FDPS
                 D04486  Ibandronate sodium (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04486
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04486
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04486
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04486
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00785  Ibandronic acid
DBLINKS     CAS: 138926-19-9
            PubChem: 47206334
            LigandBox: D04486
ATOM        21
            1   P1b P    38.0708  -27.0852
            2   O1c O    38.0708  -25.6793
            3   O1c O    36.6649  -27.0852
            4   O1c O    38.0708  -28.4911
            5   C1d C    39.4766  -27.0852
            6   P1b P    40.8825  -27.0852
            7   C1b C    39.4766  -25.6793
            8   O1a O    39.4766  -28.4911
            9   O1c O    42.2884  -27.0852 #-
            10  O1c O    40.8825  -25.6793
            11  O1c O    40.8825  -28.4911
            12  C1b C    40.6942  -24.9763
            13  N1c N    40.6943  -23.5706
            14  C1b C    41.8949  -22.8773
            15  C1a C    39.4598  -22.8577
            16  C1b C    43.0870  -23.5656
            17  C1b C    44.2834  -22.8747
            18  C1b C    45.4777  -23.5643
            19  C1a C    46.6730  -22.8741
            20  Z   Na   44.6082  -27.0149 #+
            21  O0  O    51.6600  -26.3200
BOND        18
            1     1   2 2
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     5   6 1
            6     5   7 1
            7     5   8 1
            8     6   9 1
            9     6  10 2
            10    6  11 1
            11    7  12 1
            12   12  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   16  17 1
            17   17  18 1
            18   18  19 1
///
